A detailed history of Column Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Column Capital Advisors, LLC holds 18,641 shares of PFE stock, worth $496,223. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,641
Previous 18,625 0.09%
Holding current value
$496,223
Previous $683,000 9.52%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $513 - $600
16 Added 0.09%
18,641 $618,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $32,038 - $37,067
-887 Reduced 4.55%
18,625 $683,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $34,702 - $45,177
881 Added 4.73%
19,512 $796,000
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $533,064 - $695,856
12,768 Added 217.77%
18,631 $955,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $481 - $587
11 Added 0.19%
5,863 $257,000
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $19,682 - $23,336
423 Added 7.79%
5,852 $307,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $37,103 - $45,975
811 Added 17.56%
5,429 $281,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $37,601 - $55,737
910 Added 24.54%
4,618 $273,000
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $392 - $504
10 Added 0.27%
3,708 $160,000
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $45,318 - $51,338
1,262 Added 51.81%
3,698 $145,000
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $90,360 - $109,620
-3,000 Reduced 55.19%
2,436 $79,000
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $20,218 - $28,887
-748 Reduced 12.1%
5,436 $177,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $203,577 - $231,034
6,184 New
6,184 $242,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Column Capital Advisors, LLC Portfolio

Follow Column Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Capital Advisors, LLC with notifications on news.